JANSSEN CILAG FARMACEUTICA, LDA. secures contract for 1358/2025 - Invitation To The Presentation Of A Proposal For Direct Adjustment For The Acquisition Of B466 - Bosentano [32 Mg; Buy Disp], B925 - Bedaquiline [100 Mg; Cap/Comp], T1818 - Teclistamab [90 Mg/Ml; 1.7 Ml; Only

Portugal, March 11 -- Portugal based JANSSEN CILAG FARMACEUTICA, LDA. has secured contract from Unidade Local De Saude De Sao Joao E.P.E. for 1358/2025 - Invitation To The Presentation Of A Proposal For Direct Adjustment For The Acquisition Of B466 - Bosentano [32 Mg; Buy Disp], B925 - Bedaquiline [100 Mg; Cap/Comp], T1818 - Teclistamab [90 Mg/Ml; 1.7 Ml; Only. The value of the contract is worth 64218794 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....